OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
1.950
+0.060 (3.17%)
At close: Mar 9, 2026, 4:00 PM EDT
1.980
+0.030 (1.54%)
After-hours: Mar 9, 2026, 5:09 PM EDT
OmniAb Market Cap
OmniAb has a market cap or net worth of $282.33 million as of March 9, 2026. Its market cap has decreased by -39.87% in one year.
Market Cap
282.33M
Enterprise Value
241.40M
1-Year Change
-39.87%
Ranking
Category
Stock Price
$1.95
Market Cap Chart
Since October 25, 2022, OmniAb's market cap has decreased from $992.92M to $282.33M, a decrease of -71.57%. That is a compound annual growth rate of -31.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 273.64M | 2.75% |
| Dec 31, 2025 | 266.32M | -37.83% |
| Dec 31, 2024 | 428.38M | -40.30% |
| Dec 29, 2023 | 717.57M | 73.60% |
| Dec 30, 2022 | 413.36M | -58.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 292.38M |
| Coherus Oncology | 288.48M |
| AC Immune | 282.98M |
| ALX Oncology Holdings | 281.42M |
| Abeona Therapeutics | 279.63M |
| Ovid Therapeutics | 278.59M |
| Cybin | 276.20M |
| Enlivex | 275.36M |